Status:
COMPLETED
Laryseal Pro LMA Versus Ambu Aura Gain LMA in Elective Ophthalmological Surgeries
Lead Sponsor:
Cairo University
Conditions:
Laryngeal Masks Comparison
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
Tracheal intubation is considered the gold standard for protecting the airway. As the supraglottic airway devices (SADs) could be inserted without laryngoscopy, so that SADs with different designs and...
Eligibility Criteria
Inclusion
- Age: 18-55 years old
- ASA I\& II
- Both sexes
- El-Ganzouri Airway Score \< or =2
Exclusion
- Active upper respiratory tract infections, pneumonia, COPD \& exacerbated bronchial asthma.
- History of obstructive sleep apnea (OSA) or STOP Bang-Score \> 4.
- Potentially full stomach (trauma, morbid obesity BMI\> 35 Kg/m2, pregnancy, history of gastric regurgitation and heart burn).
- Esophageal reflux (hiatus hernia).
- Coagulation disorders.
- Patients with any cardiac conditions (IHD, RHD, decompensated heart failure and arrhythmia).
Key Trial Info
Start Date :
November 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 17 2024
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06140667
Start Date
November 17 2023
End Date
July 17 2024
Last Update
September 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesia, Surgical ICU, and Pain Management
Cairo, Egypt, 11562